Cargando…

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies

BACKGROUND: Prenatal screening for chromosome aneuploidies have constantly been evolving, especially with the introduction of cell-free fetal DNA (cfDNA) screening in the most recent years. This study compares the performance, costs and timing of test results of three cfDNA screening implementation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Tianhua, Gibbons, Clare, Rashid, Shamim, Priston, Megan K., Bedford, H. Melanie, Mak-Tam, Ellen, Meschino, Wendy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686697/ https://www.ncbi.nlm.nih.gov/pubmed/33228595 http://dx.doi.org/10.1186/s12884-020-03394-w

Ejemplares similares

Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia
por: Huang, Tianhua, et al.
Publicado: (2022)

Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy–associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1–placental growth factor ratio in the early second trimester
por: Huang, Tianhua, et al.
Publicado: (2023)

A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21
por: Wang, Shuxian, et al.
Publicado: (2022)

Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13
por: Bestwick, Jonathan Paul, et al.
Publicado: (2019)

Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin
por: Kleinfinger, Pascale, et al.
Publicado: (2022)

Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023)

Prenatal biochemical screening and long term risk of maternal cardiovascular disease: population based cohort study
por: Ray, Joel G, et al.
Publicado: (2018)

Prenatal Biochemical Screening and a Woman’s Long-Term Risk of Cancer: A Population-Based Cohort Study
por: Park, Alison L, et al.
Publicado: (2019)

Prenatal Screening of Trisomy 21: Could Oxidative Stress Markers Play a Role?
por: Buczyńska, Angelika, et al.
Publicado: (2021)

The significance of trisomy 7 mosaicism in noninvasive prenatal screening
por: Qi, Yiming, et al.
Publicado: (2019)

Optimization of regional median equations of prenatal screening markers for trisomy 21 in a Chinese population
por: Xu, Liangpu, et al.
Publicado: (2018)

An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)

Clinical evaluation of the IONA test: a non‐invasive prenatal screening test for trisomies 21, 18 and 13
por: Papageorghiou, A. T., et al.
Publicado: (2015)

MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21
por: Kazemi, Mohammad, et al.
Publicado: (2017)

Non-invasive prenatal test to screen common trisomies in twin pregnancies
por: Motevasselian, Mahtab, et al.
Publicado: (2020)

Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021)

Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000–2013
por: de Groot- van der Mooren, Maurike D., et al.
Publicado: (2018)

Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
por: Neyt, Mattias, et al.
Publicado: (2014)

Beyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening
por: Metcalfe, Amy, et al.
Publicado: (2014)

A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States
por: Walker, Brandon S., et al.
Publicado: (2015)

Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21
por: Volk, Marija, et al.
Publicado: (2013)

Prenatal diagnosis of trisomy 8 mosaicism, initially identified by cffDNA screening
por: Hu, Junjie, et al.
Publicado: (2022)

Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21
por: Shen, Ori, et al.
Publicado: (2014)

Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester
por: Engell, Anna Elise, et al.
Publicado: (2017)

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester
por: Luo, Wei, et al.
Publicado: (2023)

Clinical Significance of Non-Invasive Prenatal Screening for Trisomy 7: Cohort Study and Literature Review
por: Zhu, Xiaofan, et al.
Publicado: (2020)

Clinical Efficiency of Non-invasive Prenatal Screening for Common Trisomies in Low-Risk and Twin Pregnancies
por: Xu, Yanfei, et al.
Publicado: (2021)

Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism
por: Huijsdens-van Amsterdam, Karin, et al.
Publicado: (2012)

Performance of non-invasive prenatal testing for trisomies 21 and 18 in twin pregnancies
por: Yang, Jiexia, et al.
Publicado: (2018)

Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing
por: Qiang, Rong, et al.
Publicado: (2017)

Comparing Non-invasive Prenatal Testing With Invasive Testing for the Detection of Trisomy 21
por: Mokhtar, Rifat, et al.
Publicado: (2022)

Use of Placental Growth Factor for Trisomy 21 Screening in Pregnancy: A Systematic Review
por: Badeghiesh, Ahmad, et al.
Publicado: (2020)

Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta
por: Guibourdenche, Jean, et al.
Publicado: (2023)

Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
por: Soster, Erica, et al.
Publicado: (2023)

Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms
por: Ghanta, Sujana, et al.
Publicado: (2010)

An unusual combination of trisomy 21 and partial trisomy 5q.
por: Kim, C. J., et al.
Publicado: (1992)

User Experience of a Computer-Based Decision Aid for Prenatal Trisomy Screening: Mixed Methods Explanatory Study
por: Agbadje, Titilayo Tatiana, et al.
Publicado: (2022)

Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21
por: Lim, Ji Hyae, et al.
Publicado: (2014)

Outcome after Prenatal Diagnosis of Trisomy 13, 18, and 21 in Fetuses with Congenital Heart Disease
por: Springer, Stephanie, et al.
Publicado: (2022)

Arciform Eruptions of Trisomy 21
por: Nikam, Balkrishna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fqg16di8hpt1rsgprdkjg137sa